Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


The Interest of the Xylocaine® and Ketamine on the Per and Postoperative Management of Acute and Chronic Postoperative Pain After Colectomy by Laparoscopy


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT02969733

Organisation Name: University Hospital, Lille

Overal Status: Completed

Start Date: January 2011

Last Update: September 12, 2017

Lead Sponsor: University Hospital, Lille

Brief Summary: Recent clinical studies in abdominal surgery have shown that the use of Xylocaine® parenterally intraoperative at plasma concentrations below the toxic threshold of 5 .mu.g / ml, had an analgesic effect and decreased postoperative morphine consumption.

This study aims to evaluate the activity of Xylocaine® and ketamine separately administered parenterally, in terms of postoperative morphine consumption and decrease incidences of postoperative chronic pain at 3 and 6 months after laparoscopic colectomy compared the placebo group.

The evaluation of the intensity of postoperative pain, hyperalgesia perished skin surface scarring) and pain perception threshold by Pain Matcher® confirm or not the predictive nature of these criteria in the occurrence of chronic pain.

Conditions:
  • Pain, Postoperative


Total execution time in seconds: 0.16712403297424